The 2026 NCCN Bladder Cancer Guidelines incorporate the IBCG five-factor model, introducing standardized risk stratification for intermediate-risk NMIBC. For decades, heterogeneity in ...

Recently, a research team led by Prof. Wang Hongzhi from the Hefei Institutes of Physical Science, Chinese Academy of ...

Investigators developed and validated new PSMA-PET-based nomograms for prognostication across prostate cancer stages to help guide management.

Emerging evidence links popular weight-loss drugs to lower cancer rates, but are these effects real, or simply a reflection of better metabolic health?

The challenge is that the tumor immune microenvironment is not a static backdrop but a constantly shifting ecosystem shaped by cancer cells, immune cells, stromal cells, cytokines, and physical ...

Scientists are using proteomics to decode the complex biology of endometriosis, revealing protein patterns that could enable earlier, non-invasive diagnosis and more personalized care.

Given the success of Volume I of this Research Topic, and how rapid the subject area is evolving, we are pleased to announce the launch "Liquid Biopsy in ...

A team of researchers at Baylor College of Medicine, St. Jude Children’s Research Hospital, Texas Children’s Hospital and ...

FDA review uncertainty, failed phase 3 for ersodetug in HI, high-risk upLIFT trial, tight cash runway—read more macro ...

Long-term mortality and biochemical cure rates did not differ significantly between lobectomy and total thyroidectomy in sMTC.

Using routine clinical data, the model gauges liver cancer risk better than existing tools, offering a potential way to identify high-risk patients missed by current screening criteria.